JUN 22, 2019 10:27 AM PDT

Progress on a Potential Drug for Inflammatory Disease

WRITTEN BY: Carmen Leitch

A team of researchers is trying to develop a treatment for chronic inflammatory disorders by inhibiting a complex called the NLRP3 inflammasome, which is an important player in inflammation. An inhibitory molecule has already been created - MCC950; now researchers have demonstrated how it works, moving the drug one step closer to the clinic. The findings have been reported in Nature Chemical Biology and are outlined in the following video.

Inflammation is an important part of the body’s natural response to injury and microbial infection. But it has to be controlled carefully; too much inflammation can cause health problems and disease.

"Inflammation helps our bodies heal following infection, but when the inflammasome is not switched off, inflammation becomes damaging," said one of the study leaders, Dr. Rebecca Coll of the Institute for Molecular Bioscience at the University of Queensland (UQ). "Uncontrolled inflammation results in chronic diseases, such as Parkinson's disease, Alzheimer's disease, and respiratory diseases such as asthma."

"We previously identified a small molecule, MCC950, that inhibits the inflammasome to block inflammation in disease but, until now, we did not understand how it worked," explained another study leader, Associate Professor Kate Schroder of UQ's Institute for Molecular Bioscience. "We discovered that MCC950 binds directly to the inflammasome and inactivates it, turning off inflammation. Now that we understand how a small molecule can inhibit the inflammasome, we are very excited about the potential of inflammasome inhibitors as anti-inflammatory drugs."

In this work, the researchers found that MCC950 interacts with a very specific part of one domain of NLRP3, the Walker B motif. In doing so, it halts the formation of the inflammasome by preventing the hydrolysis of ATP.

Related: Getting Rid of Damaged Mitochondria Relieves Autoimmune Disease in Mice

"UQ start-up Inflazome Ltd, which is developing targeted therapies for inflammatory diseases, had announced its plans to commence clinical trials of their inflammasome inhibitors in 2019, and other companies are competing in this space," added study co-leader Professor Avril Robertson of UQ's School of Chemistry and Molecular Biosciences. "We are keen to see results of these trials and hope that our discovery can lead to the efficient design of new molecules as anti-inflammatory drugs of the future."

Sources: AAAS/Eurekalert! via UQ, Nature Chemical Biology

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUN 16, 2021
Cell & Molecular Biology
A Potential Way to Prevent Metastatic Cancer
JUN 16, 2021
A Potential Way to Prevent Metastatic Cancer
Metastatic cancer is the deadliest, and it can happen years after cancer has been treated to the point of remission. Met ...
JUN 20, 2021
Microbiology
Bacteria Can Shape-Shift to Survive in Different Conditions
JUN 20, 2021
Bacteria Can Shape-Shift to Survive in Different Conditions
Escherichia coli bacteria are known to live in the gut, and they can also sicken people if they contaminate food that ge ...
JUL 01, 2021
Immunology
Simple Dietary Changes Could Help Ease Skin and Joint Inflammation
JUL 01, 2021
Simple Dietary Changes Could Help Ease Skin and Joint Inflammation
Eating too much sugar and fat can have a dramatic impact on the gut microflora, which in turn can flare up inflammatory ...
JUL 02, 2021
Genetics & Genomics
Fish Models Provide New Insight Into Rare Genetic Diseases
JUL 02, 2021
Fish Models Provide New Insight Into Rare Genetic Diseases
Fish can serve as good research models. They can develop quickly, outside of the mother where they can be observed. Some ...
JUL 04, 2021
Genetics & Genomics
New Insights Into the Mechanisms of Rett Syndrome
JUL 04, 2021
New Insights Into the Mechanisms of Rett Syndrome
Rett syndrome is a neurological disorder that mostly affects girls; affected individuals develop normally until they're ...
JUL 21, 2021
Cell & Molecular Biology
Human Contact Increases Antibiotic Resistance Carried by Galapagos Tortoises
JUL 21, 2021
Human Contact Increases Antibiotic Resistance Carried by Galapagos Tortoises
Even Giant Galapagos Tortoises, (seen here migrating in a photo by Juan Manuel García) are not safe from the world's ant ...
Loading Comments...